has been investigated with respect to phenotypic and genetic variations resulting in differential stuseeptibility to bactericidal antibody. Previous studies had shown that after growth in infected rats or in dialysate of rat serum, H.i.b strain Eag became more resistant to the bactericidal activity of antisomiiatic antibodly. We now report that a similar phenotypic shift occurs when strain Eag is incubated with dialysate of human serum, that the increased resistance is to antibodies against determinants in the lipopolysaccharide not for the somatic antigens generally, and that most strains of H.i.b undergo the shift.
INTRODUCTION
The capsular polysaccharide (PRP)1 is a principal virulenice determiniant in invasive infections by Haemiophilhs inifluenzae type b (H.i.b) (1, 2) . Anti-PRP antibodies proved therapeutic when passively administeredl for H.i.b meningitis (2) , and PRP-vaccinated children 1.5-6 yr old appeared to be protected in a recent field trial (3) .
Potentially protective antibodies may be directed also against somiiatic antigens (here defined as surface components other than PRP). Because the finding that complement-dependent serumn bactericidal (BC) antibody in healthy human subjects has an age distribution inverse to the incidence of H.i.b meningitis (4, 1), serumi BC activity has been viewed generally although not universally (5) as an indicator of imamunity. BC activity was reported in human sera in which anti-PRP antibody was not detected (6, 7) or-in light of more sensitive assays-sera in which anti-PRP titers appeared insufficient for BC activity (8, 9) . BC (7, 10) and opsonic (7) activity remained in certain sera despite adsorption with purified PRP. In experimental animals antisomatic antibodies can facilitate bloodstream clearance (11) and protect against lethal challenge (12, 13) .
The relevance of antisomatic antibodies for host resistance was somewhat clouided, however, by the finding that H.i.b strain Eag grown in conventional broth medium is more susceptible to the BC activity of rat antisomatic antibodies than the same strain obtained from experimentally infected rats. This differential could be mimicked by brief exposure of broth- grown bacteria to component(s) of rat serum of <1,000 mol wt (14) . In the present report such a phenotypic shift is shown to occur also in response to dialyzable components of human serum and is further described in respect to antigen specificity and strain distribution. The somatic antigens of H.i.b are not well described biochemically. As expected of a gram-negative bacterium, the outer membrane of H. influenzae Rd (rough variant of type d) was found to contain lipopolysaccharide (LPS) and a number of proteins, but the antigenicity of these components was not studied (15) . Phenol extraction of H.i.b yielded a toxic fraction resembling LPS (16) . Rabbits immunized with H.i.b produced antibodies to LPS as well as to PRP (17) ; whether the anti-LPS antibodies were bactericidal to intact H.i.b was not studied. LPS from H.i.b strain Eag recently has been isolated and partially characterized biochemically (18) . This preparation has been used in the present study to examine the extent to which antisomatic bactericidal antibodies can be LPSdirected. Tables II   and IV ; all but one were isolated from cerebrospinal fluid.
The preservation of strains and the initiation and quantitation of liquid cultures have been described (7) . Bacteria were grown at 37°C in shaken, baffled flasks to a density of 109 colony-forming units (CFU)/ml in BHI-BD broth, which is brain heart infusion (Difco Laboratories, Detroit, Mich.) supplemented with horse blood lysate and NAD (7); they were chilled to 0°C and used within 1 h after chilling. For washed bacteria, the culture was centrifuged 10 min at 8,000 g, and the bacterial pellet was suspended to original volume in the washing fluid and recentrifuged.
Sera and serum reagents. Human anti-PRP serum was obtained 2 wk after subcutaneous injection of an adult volun-teer with 30 ,ug of the purified antigen from strain Eag (21) in saline. Rabbit antisera to LPS of strain Eag (LPSEa,) (18) were produced by three intravenous injections of 0.5 ,ug at weekly intervals followed by 12 injections of 100 ,ug given twice weekly. Rabbit antisera to whole H.i.b were raised by intravenous injection of live bacteria washed in phosphate-buffered saline (7) ; an initial dose of 106 CFU was followed by three doses of 108 at weekly intervals. For adsorption of serum with H.i.b the bacteria were washed in phosphate-buffered saline containing 0.15 mM CaCl2, 0.5 mM MgCl, and 0.1% bovine serum albumin (PCMA). The washed bacterial pellet was suspended in chilled serum at 3 x 1010 CFU/ml; after 1 h at 0°C the suspension was centrifuged and the supernate transferred to a fresh bacterial pellet; after 1 h the suspension was centrifuged and the supemate further clarified by passage through a 0.22-,um filter (Millex, Millipore Corp., Bedford, Mass.). The adsorbed reagent was considered satisfactory if the BC titer against the adsorbing strain was <2; otherwise the adsorption was repeated. The term adsorption is also applied to fluid-phase inhibition with excess PRP or LPSEag; this was done by adding the inhibitor in a negligible volume of water to achieve 40 ,ug/ml and incubating 15 min at 370C followed by 2 h at 0°C. Completeness of inhibition was established for PRP by radioantigen binding (22) and for LPS by an enzyme-linked immunoadsorbent assay (23) . As a control against nonspecific inhibition of BC activity by soluble components eluted from the bacteria, by the added PRP or LPS, or by immune complexes, the adsorbed reagents were tested in the BC assay against antibody-sensitized H.i.b, prepared by incubation of the bacteria 30 min at 0°C with heat-inactivated human anti-PRP serum at 1:160 dilution. None of the reagents employed inhibited killing of the sensitized H.i.b by complement.
The complement source for the BC assay was serum from a calf denied colostrum (kindly provided by J. B. Robbins, Bureau of Biologics, U. S. Food and Drug Administration).
Dialysates of normal human sera were prepared by aseptic dialysis from a sac of cellulose membrane, 12,000-mol wt exclusion, into equal volumes of PCMA at 4°C overnight; the dialysates were stored at -70°C.
BC assay. Bacteria were prepared for the assay by dilution to 105 CFU/ml in PCMA at 0°C. For preincubation with human serum dialysate, equal volumes of this suspension and the dialysate were incubated 30 min at 370C and chilled to 0°C; the viable count approximately doubled, compensating for the 1:1 dilution. Incubation of the bacterial suspension 30 min at 37°C in PCMA alone had no effect on susceptibility. A mixture consisting of one part bacterial suspension, two parts complement source and five parts PCMA was made at 0°C, and 25 ,ul was added to 25 ,ul of (serial dilutions in PCMA of) the serum being tested for antibody. After 30 min of incubation at 370 the viable count was compared with an antibody-free control incubation, and the reciprocal of the greatest dilution giving >50% reduction was recorded as the BC titer.
Patients. Baby girl Tur was admitted to Children's Medical Center, Boston with H.i.b meningitis at age 10 were used for immunization, adsorption, and testing. In all, antisera were made against 11 strains (one to three rabbits per strain), and 53 adsorbed reagent antisera were eventually tested. Equivalently prepared reagents from different rabbits generally gave the same result; where results differed, the broadest activity was taken as the most meaningful. (Table III) . A shift likewise was seen in resistance to the anti-Eag/Mad reagent but not to the other reagents of Table II (not illustrated) .
Subtyping of isolates in recurrent infection. The six reagent antisera were applied to pairs of isolates from children who had had two systemic H.i.b infections (Table IV) . Isolate 1 from patient Tur lacked susceptibility to all six reagents; her isolate 2, however, was killed with the reagent for antigen 1. This difference was also appreciated in their susceptibility to antiLPSEag (titers of <40 and 3320, respectively). Both isolates from patient Sil were susceptible to the antigen 1 reagent, were susceptible to anti-LPSEag at equal titers, and exhibited the phenotypic shift (not illustrated) with either reagent. Discrimination was sought further with reagents consisting of the patients' own
Variations in Somatic Antigens of Haemophilus influenzae Type b convalescent sera adsorbed with PRP and LPSEag (Table IV) . Reagents prepared from the convalescent sera of Tur (after both infections) failed to kill either Tur isolate at titers useful for analysis (34). The reagent from the first convalescent serum of Sil was similarly inactive, but she responded to the second infection with antibodies that (after the adsorptions) killed her second isolate at a higher titer than her first isolate (titers 16 and 4, respectively). Thus in both patients the second infecting strain differed discernibly from the first in expression of somatic antigens. (14) . A similar effect was recently reported for another strain exposed to whole, heat-inactivated normal rat serum (13) , although components high in molecular weight such as blocking antibody, were not ruled out as effectors. The present finding that incubation with the dialysate of human serum (three of three tested) induces a shift suggests that normal component(s) of mammalian serum are responsible and that the phenomenon is relevant to the analysis of human immunity. A shift was seen in all but three of the H.i.b isolates tested (and might have been demonstrable in these ifantisera to their LPS had been available); thus it appears to be a general property of H.i.b. The shift is in resistance to antibodies directed against determinant(s) in LPS rather than against somatic antigens in general. The restricted specificity suggests that the alteration operates at the level of antibody binding rather than at subsequent stages ofcomplement-mediated bacteriolysis. Moreover, although only bacteriolysis has been examined, it seems possible that antibody-mediated opsonization or other antibody-mediated immune mechanisms would likewise be affected by the shift.
The component(s) of serum causing the shift and the For most questions concerning immunity it is of course preferable to examine bacteria as they exist in vivo. Use of bacteria harvested from infected hosts, however, would be impractical for many types ofexperiments. In respect to BC antibody susceptibility, brothgrown H.i.b briefly exposed to rat serum dialysate resembled H.i.b recovered from the circulation of infected rats (14) . It should not be concluded that the incubation with dialysate confers a phenotype equal in every respect to that in vivo, but the dialysate apparently generates a closer approximation. The bacteria prepared without and with dialysate were identical in susceptibility to antiserum reagents specific for antigens 2-6 and differed only in expression of factor 1 (plus an undefined factor present in LPSEag and in strain H123). Factor 1, however, was the most broadly distributed of the factors identified. Use of conventionally prepared bacteria for determination of serum bactericidal activities thus tends to inflate the apparent titers, particularly in sera low in anticapsular antibodies (such as sera of human infants). Even H.i.b grown in media with a high content of animal blood, e.g., Levinthal medium (2) , might be hyper-susceptible, because when brain heart infusion broth was present during exposure to dialysate the phenotypic shift was antagonized (14) . Thus surveys correlating immune status with serum bactericidal or opsonic activity against an index organism may be subject to misinterpretation as a result of phenotypic variation within a strain and genetic differences among strains.
There is considerable genetic variation in the expression of antibody-accessible antigens of H.i.b: among the 13 strains initially analyzed, seven different patterns of susceptibility to cross-adsorbed antisera were found. The results could be accounted for by the variable expression of as few as six antigens.
Use of antiserum to LPSEag suggested an additional determinant present in LPSEag and expressed in strain H123 but distinct from antigen 1. Examination of four additional isolates (from recurrent infections) revealed yet another differentially expressed antigen.
Some BC activity of the cross-adsorbed antisera conceivably could be the result of variant determinants in capsular polysaccharide; however, no such variation has been reported. PRP from strains Eag, Rab, H305, and Mad were alike in composition (24) , and the two former were found to be structurally identical (25, 26) . Because four ofthe reagent antisera were raised against these strains, at least four of the variable antigens appear to be somatic rather than capsular. Antigen (Table I) , so the corresponding determinants either are not a part of LPS or are not conserved when LPS is purified (18) by the phenol-water method. The possible relation ofnon-LPS-adsorbed somatic BC anti-bodies and the outer membrane proteins of H.i.b is currently under study.
In the patients with recurrent systemic infections the second isolates were shown to differ from the first in antigens expressed. This observation is more consistent with the second illnesses being due to newly acquired strains of H.i.b rather than to recrudescence of sequestered organisms from the first infections. Two of these strains will be of particular interest in further study of the distribution and surface exposure of somatic antigens of H.i.b: strain Tur 1 expressed no somatic antigens susceptible to the six reagent antisera or to antibodies elicited in the patient. It will be of interest to determine whether it exposes somatic antigens not apparent in this study or exposes none. Strains Sil 1 and 2 were identical in respect to the antigens 1-6, but Sil 2 was more susceptible to an antibody elicited in the patient. Thus Sil 2 and Tur 1 (along with H123) would be useful for extending the subtyping system. Somatic antigens may be pertinent to vaccination against H.i.b. The human antibody response to vaccination with purified PRP is age dependent (27, 8) . PRP vaccine appeared to be protective only after age 18 mo (3), whereas the maximal incidence of H.i.b meningitis occurs in the first year of life. Antibody-accessible somatic antigens to which immunocompetence matured early in human development would be useful to identify, particularly such an antigen homogeneously distributed among H.i.b strains. The cross-adsorbed antisera used here would lack antibody to a universal somatic antigen but would be useful in discerning it from the variably expressed antigens. In addition, H. influenzae otitis media is primarily the result of unencapsulated strains, and their somatic antigens might reasonably be examined for immunoprotective potential. Thus an antigen common to H.i.b and H.i. causing otitis would be ideal. Further biochemical and immunological studies will be required to determine whether such an antigen exists.
